drugset / Trial / NCT01783977
Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults
RandomizedParallel-groupQuadruple-blindPrevention
Summary
NOTE: This study has stopped enrolling new participants, and all study vaccinations for currently enrolled participants have been stopped. Currently, there are no vaccines approved for the prevention of HIV infection, but there are many clinical trials taking place that are studying experimental HIV vaccines. The purpose of this study is to evaluate the safety and tolerability of three different HIV vaccine schedules in healthy, HIV-uninfected adults.
Timeline
- Start
- 2013-04
- Primary completion
- 2014-09
- Completion
- 2018-10-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DNA-HIV-PT123 | Vaccine | 1 ml | Intramuscular |
| Subject | NYVAC-HIV-PT1 | Vaccine | 1 ml | Intramuscular |
| Subject | NYVAC-HIV-PT4 | Vaccine | 1 ml | Intramuscular |